Skip to search formSkip to main contentSkip to account menu

Triptans

Derivatives of TRYPTAMINES that are SEROTONIN RECEPTOR AGONISTS acting at 5-HT1 RECEPTORS. Some are used to treat MIGRAINE DISORDERS.
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Serotonin 5-HT1 Receptor AgonistsTryptamines

Narrower (1)

Sumatriptan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Part II--Management of pediatric post-traumatic headaches.
Highly Cited
2012
Highly Cited
2012
Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease
Objective.— To evaluate the efficacy of telcagepant in patients with migraine and coronary artery disease. 
Review
2011
Review
2011
The Extracranial Vascular Theory of Migraine—A Great Story Confirmed by the Facts
Over the years, there has been a considerable amount of controversy as to whether the vascular component of migraine pain arises… 
2010
2010
Selective Inhibition of 5‐HT7 Receptor Reduces CGRP Release in an Experimental Model for Migraine
Objective.— To investigate the role of 5‐HT7 receptors on the release of calcitonin gene‐related peptide (CGRP) in an animal… 
Highly Cited
2009
Highly Cited
2009
Zelrix™: A Novel Transdermal Formulation of Sumatriptan
Objective.— This study evaluated the pharmacokinetic and tolerability profiles of Zelrix™ (NuPathe Inc., Conshohocken, PA, USA… 
2008
2008
Analysis of Headache Management in a Busy Emergency Room in the United States
Objectives.— To analyze the demographics, diagnosis, and treatment patterns in patients with headache‐seeking treatment in one of… 
2003
2003
Efficacy of a Fixed Combination of Indomethacin, Prochlorperazine, and Caffeine Versus Sumatriptan in Acute Treatment of Multiple Migraine Attacks: A Multicenter, Randomized, Crossover Trial
Objective.—To compare the efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine suppositories with… 
Review
2001
Review
2001
Current options for the prevention and treatment of migraine.
Review
2001
Review
2001
Triptans are all different.
T HERE ARE 4 triptans currently available in theUnitedStates, and 3moreareexpectedto be approved by the Food and Drug… 
Review
1999
Review
1999
Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)